nothing new, although we have a guideline on time scales on what we want to achieve ....
Mid to end of next year until proving up more with the mice before IND end of next year with if everything going ok early 2021 for clinic......
LOL.....Long time to accumulate and nothing much i wouldnt think coming from left field to increase sp..
Simple, more testing needed and clinic is the must if is ever to be taken serious by the majors.
Ann: PAB Business Review - 30 June 2019, page-2
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.7¢ | $19.16K | 2.732M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 361174 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1874624 | 9 |
View Market Depth
| Last trade - 12.24pm 24/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |